What is EyeQue?
Founded in 2015 and headquartered in Newark, California, EyeQue operates at the intersection of healthcare technology and patient empowerment. The company collaborates closely with eye care professionals to offer unique at-home solutions that enable patients to update their prescriptions between regular appointments, meticulously track treatment efficacy for specific conditions, and monitor their progress post-procedure. By facilitating the adoption of telemedicine, EyeQue aims to support the expansion of eye care practices while simultaneously catering to the growing consumer interest in proactive health management and self-care.
How much funding has EyeQue raised?
EyeQue has raised a total of $72.7M across 4 funding rounds:
Series A
$3.5M
Series B
$11.2M
Debt
$1M
Series C
$57M
Series A (2016): $3.5M with participation from Align Capital
Series B (2018): $11.2M, investors not publicly disclosed
Debt (2020): $1M supported by PPP
Series C (2021): $57M, investors not publicly disclosed
Key Investors in EyeQue
PPP
Public-Private Partnership
What's next for EyeQue?
With the recent influx of major strategic investment, EyeQue is poised for an accelerated growth trajectory. The company's focus on integrating telemedicine into routine eye care suggests a strategic expansion into broader digital health markets. Future developments are likely to center on enhancing the capabilities of their at-home diagnostic tools, expanding partnerships with eye care providers, and potentially exploring new therapeutic areas within vision health. This enterprise-level backing signals strong investor confidence in EyeQue's model for improving patient outcomes and practice efficiency in the digital age.
See full EyeQue company page
